← Open Payments lookup

NATHANIEL BROOKS: Open Payments

NPI 1659728731 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,341 in 151 payments from 16 companies in 2025. Trend: 2023 $1,514 · 2024 $2,592 · 2025 $2,341

Food & beverage: $2,230Education: $111
CompanyPaymentsAmount
ABBVIE INC.61$520
Supernus Pharmaceuticals, Inc.18$318
Vanda Pharmaceuticals Inc.11$261
Teva Pharmaceuticals USA, Inc.6$221
Takeda Pharmaceuticals U.S.A., Inc.13$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$167
Otsuka America Pharmaceutical, Inc.6$161
Lundbeck LLC11$141
Almatica Pharma LLC4$91
Axsome Therapeutics, Inc.3$82

Products named: VRAYLAR, Qelbree, REXULTI, FANAPT, TRINTELLIX, CAPLYTA, AUSTEDO XR, LOREEV XR.

Industry payments across AZ — which companies pay providers there.